Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercebiotech.com

FierceBiotech

Get the latest updates from FierceBiotech directly as they happen.

Follow now 339 followers

Latest posts

Last updated about 2 hours ago

Amgen abandoning $500M+ Crohn’s collab won't derail TScan’s strategy

about 2 hours ago

Amgen is walking away from a Crohn’s disease collaboration with TScan Therapeutics...

Merck and Sarah Cannon team up to boost oncology trial efficiency

about 18 hours ago

Oncology R&D organization Sarah Cannon Research Institute (SCRI) announced a collaboration with...

Trump looks set to tap White House aide Heidi Overton as next FDA commissioner

about 19 hours ago

After three months without a permanent leader in place, President Donald Trump...

A ‘renaissance for biomedicine’: human brain organoids model development for 5 years

about 20 hours ago

Scientists’ ability to recapitulate the human brain in a dish has always...

Tolerance Bio jumps into phase 2 with $260M deal for thymus-targeting fusion protein

about 21 hours ago

Tolerance Bio has vaulted into the clinic by agreeing to pay NeoImmuneTech...

New Biotech-Academia Partnership Approaches to Empower the Drug Development Ecosystem

about 21 hours ago

Addressing shifts in the global clinical development ecosystem and how academia and...

Developing a Global Clinical Trial Strategy for Emerging Biotechs

about 21 hours ago

Discussing how small biotechs can accelerate clinical development with fit-for-purpose global clinical...

How Pharma Teams Evaluate Biotech Companies for Partnerships and Acquisitions

about 21 hours ago

Addressing how interactions around partnerships or acquisitions differ from those of investment...

Merck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval push

about 24 hours ago

Merck & Co. and Moderna's personalized mRNA cancer vaccine has successfully lengthened...

Kolon TissueGene shrinks workforce after pivotal osteoarthritis trial miss

1 day ago

Following a phase 3 knee osteoarthritis failure that its CEO acknowledged caused...

Merck and Sarah Cannon team up to boost oncology trial efficiency

1 day ago

Oncology R&D organization Sarah Cannon Research Institute (SCRI) announced a collaboration with...

Craif raises $33M to boost work on its urine test for cancer

2 days ago

The AI biopharma Craif has raised $33 million in its series D...